Stock Region Research
Subscribe
Sign in
Share this discussion
Health Company Granted FDA Orphan Drug Status For Marburg Virus Prophylaxis
stockregion.app
Copy link
Facebook
Email
Note
Other
Health Company Granted FDA Orphan Drug Status…
Stock Region
Apr 15
Share this post
Health Company Granted FDA Orphan Drug Status For Marburg Virus Prophylaxis
stockregion.app
Copy link
Facebook
Email
Note
Other
FDA Grants Orphan Drug Status to Soligenix's MarVax™: A Turning Point in Marburg Virus Prophylaxis.
Read →
0 Comments
Share
Share
Copy link
Facebook
Email
Note
Other
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
Health Company Granted FDA Orphan Drug Status For Marburg Virus Prophylaxis
Health Company Granted FDA Orphan Drug Status…
Health Company Granted FDA Orphan Drug Status For Marburg Virus Prophylaxis
FDA Grants Orphan Drug Status to Soligenix's MarVax™: A Turning Point in Marburg Virus Prophylaxis.